DOD Biotech Public Company Limited
DOD Biotech Public Company Limited, together with its subsidiaries, manufactures and distributes dietary supplements in Thailand. It offers dietary supplements for beauty and health in various forms comprising capsules, gels, jellies, powder, shot drinks, soft gels, tablets, probiotics, gummies, and direct-to-mouth. The company also provides food supplements and health drinks. In addition, it off… Read more
DOD Biotech Public Company Limited (DOD) - Total Assets
Latest total assets as of September 2025: ฿1.11 Billion THB
Based on the latest financial reports, DOD Biotech Public Company Limited (DOD) holds total assets worth ฿1.11 Billion THB as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
DOD Biotech Public Company Limited - Total Assets Trend (2013–2024)
This chart illustrates how DOD Biotech Public Company Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
DOD Biotech Public Company Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
DOD Biotech Public Company Limited's total assets of ฿1.11 Billion consist of 47.9% current assets and 52.1% non-current assets.
| Asset Category | Amount (THB) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ฿0.00 | 17.3% |
| Accounts Receivable | ฿24.37 Million | 1.9% |
| Inventory | ฿126.88 Million | 9.9% |
| Property, Plant & Equipment | ฿0.00 | 0.0% |
| Intangible Assets | ฿43.06 Million | 3.4% |
| Goodwill | ฿252.36K | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how DOD Biotech Public Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DOD Biotech Public Company Limited's current assets represent 47.9% of total assets in 2024, an increase from 8.2% in 2013.
- Cash Position: Cash and equivalents constituted 17.3% of total assets in 2024, up from 0.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 9.9% of total assets.
DOD Biotech Public Company Limited Competitors by Total Assets
Key competitors of DOD Biotech Public Company Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
DOD Biotech Public Company Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - DOD Biotech Public Company Limited generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - DOD Biotech Public Company Limited is currently not profitable relative to its asset base.
DOD Biotech Public Company Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.38 | 1.90 | 1.44 |
| Quick Ratio | 3.42 | 1.43 | 0.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ฿355.10 Million | ฿ 270.25 Million | ฿ 204.93 Million |
DOD Biotech Public Company Limited - Advanced Valuation Insights
This section examines the relationship between DOD Biotech Public Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.82 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -11.8% |
| Total Assets | ฿1.29 Billion |
| Market Capitalization | $13.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values DOD Biotech Public Company Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: DOD Biotech Public Company Limited's assets decreased by 11.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for DOD Biotech Public Company Limited (2013–2024)
The table below shows the annual total assets of DOD Biotech Public Company Limited from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ฿1.29 Billion | -11.75% |
| 2023-12-31 | ฿1.46 Billion | +12.91% |
| 2022-12-31 | ฿1.29 Billion | -20.66% |
| 2021-12-31 | ฿1.63 Billion | -6.14% |
| 2020-12-31 | ฿1.73 Billion | +10.09% |
| 2019-12-31 | ฿1.57 Billion | +11.94% |
| 2018-12-31 | ฿1.41 Billion | +280.25% |
| 2017-12-31 | ฿369.93 Million | +29.98% |
| 2016-12-31 | ฿284.60 Million | +52.08% |
| 2015-12-31 | ฿187.14 Million | +8960.10% |
| 2014-12-31 | ฿2.07 Million | +0.00% |
| 2013-12-31 | ฿2.07 Million | -- |